Concepedia

Matthew P. Braun

MP

Statistics

Publications

28

Citations

2.5K

H-Index

23

Active since

1987

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Wayne State University

Merck Biopharma Co., Ltd. (Japan)

MSD (UK) Limited (United Kingdom)

Matthew P. Braun is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, pharmacy, and drug disposition.

Publications per year

1987–2013

28

Publications

28

The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1)

Margarita García‐Calvo, JeanMarie Lisnock, Herbert G. Bull et al. · Proceedings of the National Academy of Sciences · 2005 · 768 citations

Life Sciences, Molecular Biology, Pharmacology +14

Direct α-iodination of cycloalkenones

Carl R. Johnson, Joseph P. Adams, Matthew P. Braun et al. · Tetrahedron Letters · 1992 · 230 citations

Natural Sciences, Chemistry, Organic Chemistry +9

A two-step, three-component synthesis of PGE1: utilization of .alpha.-iodo enones in Pd(0)-catalyzed cross-couplings of organoboranes

Carl R. Johnson, Matthew P. Braun · Journal of the American Chemical Society · 1993 · 230 citations

Natural Sciences, Biochemistry, Chemistry +10

Transport of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin by Human Organic Anion Transporter 3, Organic Anion Transporting Polypeptide 4C1, and Multidrug Resistance P-glycoprotein

Xiaoyan Chu, Kelly Bleasby, Jocelyn Yabut et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 176 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Studies on Cytochrome P-450-Mediated Bioactivation of Diclofenac in Rats and in Human Hepatocytes: Identification of Glutathione Conjugated Metabolites

Wei Tang, Ralph A. Stearns, Stelvio M. Bandiera et al. · Drug Metabolism and Disposition · 1999 · 170 citations

Pharmacy, Pharmacology, Toxicology +17

1–5 of 28